scholarly journals The prevalence of nonalcoholic liver steatosis in patients with type 2 diabetes mellitus in the Czech Republic

2015 ◽  
Vol 159 (3) ◽  
pp. 442-448 ◽  
Author(s):  
Karel Dvorak ◽  
Radvan Hainer ◽  
Jaromir Petrtyl ◽  
Miroslav Zeman ◽  
Tomas Vareka ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Czech Republic ◽  
Liver Steatosis ◽  
The Czech Republic

scholarly journals Treating Patients with Type 2 Diabetes Mellitus Uncontrolled on Basal Insulin in the Czech Republic: Cost-Effectiveness of IDegLira Versus iGlarLixi

2019 ◽  
Vol 10 (2) ◽  
pp. 493-508 ◽  
Author(s):  
Johannes Pöhlmann ◽  
Monika Russel-Szymczyk ◽  
Pavel Holík ◽  
Karel Rychna ◽  
Barnaby Hunt
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Czech Republic ◽  
Cost Effectiveness ◽  
Basal Insulin ◽  
The Czech Republic

scholarly journals PDB58 - REIMBURSEMENT FOR TYPE 2 DIABETES MELLITUS PATIENTS HOSPITALIZED IN A MUNICIPAL HOSPITAL IN THE CZECH REPUBLIC

2018 ◽  
Vol 21 ◽  
pp. S127-S128
Author(s):  
V. Loncak ◽  
M. Bartak ◽  
V. Rogalewicz
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Czech Republic ◽  
Municipal Hospital ◽  
The Czech Republic

scholarly journals Analysis of Postprandial Glycemia in Relation to Metabolic Compensation and Other Observed Parameters of Outpatients with Type 2 Diabetes Mellitus in the Czech Republic

2018 ◽  
Vol 9 (2) ◽  
pp. 665-672 ◽  
Author(s):  
Denisa Janíčková Žďárská ◽  
Martin Hill ◽  
Milan Kvapil ◽  
Pavlína Piťhová ◽  
Jan Brož
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Czech Republic ◽  
The Czech Republic ◽  
Postprandial Glycemia ◽  
Metabolic Compensation

scholarly journals Results of Insulin Therapy in Type 2 Diabetes Mellitus Patients in the Czech Republic: Do They Reflect the Current Status in Other Countries?

2019 ◽  
Vol 10 (4) ◽  
pp. 1181-1188
Author(s):  
Jan Brož ◽  
Denisa Janíčková Ždárská ◽  
Jana Urbanová
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Czech Republic ◽  
Insulin Therapy ◽  
Current Status ◽  
The Czech Republic

scholarly journals Comparison of different approaches for estimation of prevalence of type 2 diabetes mellitus in the Czech Republic

2020 ◽  
Vol 66 (5) ◽  
pp. e33-e37
Author(s):  
Pavel Hroboň ◽  
Magdalena Škodová ◽  
Petra Kučová ◽  
Jana Votápková
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Czech Republic ◽  
The Czech Republic

scholarly journals Accuracy of FibroTouch in assessing liver steatosis and fibrosis in patients with metabolic-associated fatty liver disease combined with type 2 diabetes mellitus

2021 ◽  
Vol 0 (0) ◽  
pp. 0-0
Author(s):  
Hongyan Yu ◽  
Hui Liu ◽  
Jie Zhang ◽  
Guoyu Jia ◽  
Ling Yang ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Liver Disease ◽  
Fatty Liver ◽  
Fatty Liver Disease ◽  
Liver Steatosis

Clinical and biochemical determinants of the extent of liver steatosis in type 2 diabetes mellitus

2015 ◽  
Vol 27 (12) ◽  
pp. 1386-1391 ◽  
Author(s):  
Alessandra Cosma ◽  
Diego Cecchet ◽  
Silvia Gaiani ◽  
Anna Coracina ◽  
Paolo Pellizzari ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Liver Steatosis

scholarly journals The prevalence of disorders of the gut-brain axis in type 2 diabetes mellitus patients with metabolic dysfunction-associated fatty liver disease: an observational study

2021 ◽  
Vol 84 (4) ◽  
pp. 541-547
Author(s):  
T Van Nieuwenhove ◽  
G Rasschaert ◽  
A Kharagjitsingh ◽  
B Keymeulen ◽  
H Reynaert ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Liver Disease ◽  
Observational Study ◽  
Liver Steatosis ◽  
Future Research ◽  
Metabolic Dysfunction ◽  
Irritable Bowel

Background and study aim: Disorders of the gut-brain axis (DGBI) and metabolic dysfunction-associated liver disease (MAFLD) are frequently diagnosed and exhibit pathophysiological similarities. This study aimed to estimate the prevalence of DGBI in type 2 diabetes mellitus (T2DM) patients with MAFLD. Patients and methods: In this single center, observational study, in adults with T2DM demographics, diabetes-related parameters and liver tests were recorded. MAFLD was defined by the presence of hepatic steatosis on imaging. Functional dyspepsia (FD) and irritable bowel syndrome (IBS) were diagnosed based on Rome IV criteria. Quality of life (QOL), anxiety levels and depression levels were documented by validated questionnaires. Results: We included 77 patients, 44 with and 33 without steatosis. There were no significant differences in age, body mass index (BMI), waist circumference, HbA1c levels or metformin use between groups. IBS was significantly more prevalent in the liver steatosis group (9/44 vs. 2/33, p = .037), while a similar trend was observed for FD (9/35 vs. 2/31, p = .103). No differences were found in anxiety, depression and overall QOL. However, QOL subscales for health worry, food avoidance and social reaction were significantly higher in the liver steatosis group. Conclusions: In otherwise comparable T2DM patients, DGBI, and especially IBS, are more prevalent in the presence of MAFLD. This difference could not be attributed to increased levels of anxiety or depression. Future research should target the underlying pathophysiological mechanisms. (Acta gastroenterol. belg., 2021, 84, 541-547).

scholarly journals Health Economic Evaluation of Canagliflozin in the Treatment of Type 2 Diabetes Mellitus in Czech Republic

2014 ◽  
Vol 17 (7) ◽  
pp. A342-A343
Author(s):  
A. Troelsgaard ◽  
A. Pitcher ◽  
Š. Veselá ◽  
E. Lovato ◽  
M. Hemels
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Health Economic ◽  
Type 2 Diabetes Mellitus ◽  
Czech Republic ◽  
Economic Evaluation ◽  
Health Economic Evaluation
Sign in / Sign up

Export Citation Format

Share Document